Evidence map›Paper›PMID 33780543›Full record

ArticleThe Journal of infectious diseases2022

Persistent Immune Activation in Human Immunodeficiency Virus-Infected Pregnant Women Starting Combination Antiretroviral Therapy After Conception.

Barbara Lohman-Payne, Jacob Koster, Benjamin Gabriel, Roma Chilengi, Leah S Forman, Tim Heeren, Cassandra R Duffy, Julie Herlihy, Steven Crimaldi, Chris Gill and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Discordance of 3rd and 4th generation QuantiFERON-TB Gold assays by pregnancy stages in India.Journal of clinical tuberculosis and other mycobacterial diseases · 2025
    Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Barbara Lohman-PayneInstitute for Immunology and Informatics, Department of Cell and Molecular Biology, University of Rhode Island, Providence, Rhode Island, USA.ORCID 0000-0001-5244-8681
Jacob KosterNational Emerging Infectious Diseases Laboratories, Boston University Medical Campus, Boston, Massachusetts, USA.
Benjamin GabrielInstitute for Immunology and Informatics, Department of Cell and Molecular Biology, University of Rhode Island, Providence, Rhode Island, USA.
Roma ChilengiCenter for Infectious Disease Research Zambia, Lusaka, Zambia.
Leah S FormanBiostatistics and Epidemiology Data Analytics Center, Boston University School of Public Health, Boston, Massachusetts, USA.
Tim HeerenDepartments of Biostatistics, Boston, Massachusetts, USA.
Cassandra R DuffyDepartment of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Julie HerlihyDepartment of Pediatrics, Boston, Massachusetts, USA.
Steven CrimaldiDepartment of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.
Chris GillDepartment of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.
Roy ChavumaDepartment of Surgery, School of Medicine, University of Zambia, Lusaka, Zambia.
Lawrence MwananyandaDepartment of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.
Donald M TheaDepartment of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.
Boston University · USUniversity of Rhode Island · USBeth Israel Deaconess Medical Center · USCancer Research And Biostatistics · USCentre for Infectious Disease Research in Zambia · ZMUniversity of Zambia · ZM

Funding

HIV Exposed Uninfected Infant Cohort StudyR01HD094650 · NICHD · BOSTON UNIVERSITY MEDICAL CAMPUS · PI THEA, DONALD M · 2018 to 2022
$5.4M
NICHD NIH HHS R01 HD094650
6 · The paper itself

Abstract

This study evaluated the impact of human immunodeficiency virus (HIV) and combination antiretroviral therapy (cART) on immune activation during pregnancy in a Zambian cohort of HIV-exposed but uninfected children followed up from birth. Activated CD8+ T cells (CD38+ and HLA-DR+) were compared among HIV-uninfected (n = 95), cART experienced HIV-infected (n = 111), and cART-naive HIV-infected (n = 21) pregnant women. Immune activation was highest among HIV-infected/cART-naive women but decreased during pregnancy. Immune activation HIV-infected women who started cART during pregnancy was reduced but not to levels similar to those in HIV-uninfected women. The effects of elevated maternal immune activation in pregnancy on subsequent infant health and immunity remain to be determined.

Indexed as

Antiretroviral Therapy, Highly ActiveHIV InfectionsFemaleHIVHLA-DR AntigensHumansInfantInfant, NewbornPregnancyPregnant PeopleHLA-DR AntigensCD38HIV-negativeHIV-positiveHLA-DRMother-Child healthpregnancyZambia

Identifiers

PMID33780543
PMCPMC8974832
OpenAlexW3150011251

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.